• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺动脉高压(IPAH)和冠心病相关肺动脉高压(CHD-PAH)患者的血清脂质分布差异

Differential serum lipid distribution in IPAH and CHD-PAH patients.

作者信息

Chen Jingyuan, Rathinasabapathy Anandharajan, Luo Jun, Yang Xiaojie, Luo Peng, Chen Yusi, Li Zilu, Li Jiang

机构信息

Department of Cardiovascular Medicine, Second Xiangya Hospital of Central South University, Changsha City, Hunan Province, China; Research Institute of Blood Lipid and Atherosclerosis, Central South University, Changsha City, Hunan Province, China; Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Respir Med. 2022 Jan;191:106711. doi: 10.1016/j.rmed.2021.106711. Epub 2021 Dec 3.

DOI:10.1016/j.rmed.2021.106711
PMID:34890866
Abstract

Lipid homeostasis is dysregulated in pulmonary arterial hypertension (PAH). A decrease in serum high- and low-density lipoprotein cholesterol (HDL-C and LDL-C) is significantly associated with the worse prognosis of PAH. However, no study has investigated the differential distribution of lipids in various PAH subtypes. We enrolled 190 patients in this retrospective study, which includes 20 patients with congenital heart disease without PAH (CHD-nonPAH), 101 patients with PAH associated with congenital heart disease (CHD-PAH), 69 patients with idiopathic PAH (IPAH) and 81 healthy controls. Laboratory parameters such as liver and renal function, serum lipids, C-reactive protein, N-terminal pro-brain natriuretic peptide (NT-proBNP), echocardiography, right heart catheterization and 6-min walk distance (6MWD) were performed. All types of cholesterol including HDL-C, LDL-C and total cholesterol (CHOL) were significantly lower in IPAH patients in association with right heart function. Although LDL-C and CHOL were lower in CHD-PAH, they were not associated with disease severity or heart failure. Thus, we conclude that IPAH and CHD-PAH patients exhibited a differential distribution pattern of serum lipids.

摘要

肺动脉高压(PAH)中脂质稳态失调。血清高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)降低与PAH的不良预后显著相关。然而,尚无研究调查不同PAH亚型中脂质的差异分布情况。我们纳入了190例患者进行这项回顾性研究,其中包括20例无PAH的先天性心脏病患者(CHD-非PAH)、101例与先天性心脏病相关的PAH患者(CHD-PAH)、69例特发性PAH(IPAH)患者和81例健康对照。进行了肝功能、肾功能、血脂、C反应蛋白、N末端脑钠肽前体(NT-proBNP)、超声心动图、右心导管检查和6分钟步行距离(6MWD)等实验室检查。与右心功能相关,IPAH患者中包括HDL-C、LDL-C和总胆固醇(CHOL)在内的所有类型胆固醇均显著降低。虽然CHD-PAH患者的LDL-C和CHOL较低,但它们与疾病严重程度或心力衰竭无关。因此,我们得出结论,IPAH和CHD-PAH患者表现出血清脂质的差异分布模式。

相似文献

1
Differential serum lipid distribution in IPAH and CHD-PAH patients.特发性肺动脉高压(IPAH)和冠心病相关肺动脉高压(CHD-PAH)患者的血清脂质分布差异
Respir Med. 2022 Jan;191:106711. doi: 10.1016/j.rmed.2021.106711. Epub 2021 Dec 3.
2
[Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].[心肺运动试验在比较三种肺动脉高压患者心肺功能中的价值]
Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3598-601.
3
[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].[先天性心脏病相关肺动脉高压患者不同亚型的死亡危险因素及临床特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364.
4
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.CTLA-4 表达是特发性肺动脉高压有前途的生物标志物,并可区分肺动脉高压的类型。
Int J Mol Sci. 2022 Dec 14;23(24):15910. doi: 10.3390/ijms232415910.
5
Association of changes in NT-proBNP, hsTnT and uric acid levels with haemodynamic changes after targeted medical therapies in patients with idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者靶向药物治疗后 NT-proBNP、hsTnT 和尿酸水平变化与血液动力学变化的关系。
Cardiovasc J Afr. 2022;33(1):10-14. doi: 10.5830/CVJA-2021-018. Epub 2021 Nov 22.
6
[Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension].妊娠合并肺动脉高压患者死亡高危因素及其临床特征分析
Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):495-500.
7
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).先天性心脏病相关肺动脉高压患者的 4 年和 7 年结局(来自 REVEAL 登记研究)。
Am J Cardiol. 2014 Jan 1;113(1):147-55. doi: 10.1016/j.amjcard.2013.09.032. Epub 2013 Oct 4.
8
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).与甲基苯丙胺相关的肺动脉高压:来自全国肺动脉高压生物样本和数据资源库(PAH Biobank)的数据。
BMJ Open Respir Res. 2023 Dec 7;10(1):e001917. doi: 10.1136/bmjresp-2023-001917.
9
Analysis of relationship between P wave dispersion and diagnosis of pulmonary arterial hypertension and risk stratification.分析 P 波离散度与肺动脉高压诊断及危险分层的关系。
J Electrocardiol. 2023 Nov-Dec;81:94-100. doi: 10.1016/j.jelectrocard.2023.08.002. Epub 2023 Aug 12.
10
Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD.特发性肺动脉高压(IPAH)患者与先天性心脏病相关肺动脉高压(PAH-CHD)患者右心室功能及对靶向治疗反应的差异。
Front Pharmacol. 2023 Feb 13;14:1124746. doi: 10.3389/fphar.2023.1124746. eCollection 2023.

引用本文的文献

1
Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension.毛细血管前性肺动脉高压患者的肾功能不全、肝功能损害及脂质代谢异常
Diagnostics (Basel). 2024 Aug 21;14(16):1824. doi: 10.3390/diagnostics14161824.
2
Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension.血液胆固醇和甘油三酯与肺动脉高压患者的右心室功能相关。
medRxiv. 2024 Jan 22:2024.01.20.24301498. doi: 10.1101/2024.01.20.24301498.
3
The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension.
异常脂质代谢对特发性肺动脉高压发病风险的影响。
Int J Mol Sci. 2023 Sep 19;24(18):14280. doi: 10.3390/ijms241814280.
4
Impact of malnutrition on prognosis in patients with pulmonary arterial hypertension.营养不良对肺动脉高压患者预后的影响。
Pulm Circ. 2023 Sep 12;13(3):e12286. doi: 10.1002/pul2.12286. eCollection 2023 Jul.
5
Biomarkers in Pulmonary Arterial Hypertension.肺动脉高压中的生物标志物
Diagnostics (Basel). 2022 Dec 3;12(12):3033. doi: 10.3390/diagnostics12123033.
6
Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-naïve patients with systemic lupus erythematosus: D-dimer as a mediator.初诊未用药的系统性红斑狼疮患者中低密度脂蛋白降低与肺动脉高压的存在:D-二聚体作为一种介质
Exp Ther Med. 2022 Jul 27;24(3):595. doi: 10.3892/etm.2022.11531. eCollection 2022 Sep.
7
Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.入院时 CT 肺部不透明度评分与 COVID-19 患者临床特征和结局的关系。
Intern Emerg Med. 2022 Jan;17(1):153-163. doi: 10.1007/s11739-021-02795-9. Epub 2021 Jun 30.